LEONHARDT VENTURES NEWS
Leonhardt Ventures Announces Filing of Pioneering Patent Application for Bioelectric Protein Expression Control of the SIRT
SIRT signaling proteins (1-7) are involved in metabolic regulation, inflammation, neurodegeneration, cell cycle/tumorigenesis, Insulin secretion, DNA repair, and rDNA transcription and play a key role during cell response to a variety of stresses, such as oxidative or...
Executive Chairman’s Best guess estimate June 2022 on portfolio assets closest to exit
Note - ALL bioelectric products are based on same exact core stimulator with only slightly different signal sequence protocols. Nearly all use our stem cell homing and circulation improving signals common. So in sense we have only two highly focused startups...
May 9, 2022 Update Leonhardt Ventures LLC and Leonhardt’s Launchpads
Update Leonhardt Ventures LLC May 2022
Mind of an Innovator Slide Deck for Innovation Week 2022
The Mind of an Innovator Creator
Collections of quotes compiled and a summation by Howard J. Leonhardt The mind of an innovator is a mind that breaks from the tyranny of conformity despite the overwhelming pressure to be and think like everyone else. A person who creates something new that did not...
Leonhardt Ventures Announces Launch of Research Program Using Patent Pending Klotho Expressing Mesenchymal Stem Cells for Multiple Applications in Combination with Bioelectric Protein Expressions
Mission Viejo, California, United States, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Leonhardt Ventures LLC, a Mission Viejo, California based company via it's innovation and startup launch accelerator Leonhardt's Launchpads, announced today that it has begun an active...
Leonhardt Ventures LLC Issued Pioneering Patent for Bioelectric Inflammation Treatment Device and Method
Irvine, California, United States - 09/07/2021 — Patent protects methods and devices for customized real time treatment of chronic inflammation related disorders with bioelectric stimulation based protein expressions and control Irvine, California —(PRDistribution)-...
Leonhardt’s Launchpads Announces Issuance of New U.S. Patent for Bioelectric Plus Biologics Platform for Organ Regeneration and Healing
Latest Patent Further Strengthens Intellectual Property Portfolio Covering Novel Platform for Precisely Controlling Regenerative Protein Expressions Including Stem Cell Homing and Differentiation Control Technology Has Key Potential Applications in Regeneration of...
Leonhardt’s Launchpads Accelerator To Showcase Eight Innovation Assets and Startups At 2022 Demo Day
Showcased technologies include a novel circulatory assist pump for heart failure and bioelectric and biologic treatments for erectile dysfunction, skin and hair regeneration, and rapid straightening and stabilization of teeth during orthodontic treatment. NEWS...
Leonhardt Ventures Announces Issuance of Pioneering U.S. Patent for Multi-Modality Customized Bioelectric Treatment of Cancer
Published: Dec 22, 2021 Mission Viejo, California, United States, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Leonhardt Ventures LLC, a pioneer in developing bioelectric and biologic innovations for organ regeneration and healing, today announced that the U.S. Patent and...